JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 11, 2004; DOI: 10.1124/jpet.103.064717


0022-3565/04/3101-417-424$20.00
JPET 310:417-424, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.064717v1
310/1/417    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nanji, A. A.
Right arrow Articles by Bass, N. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nanji, A. A.
Right arrow Articles by Bass, N. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CLOFIBRATE
*ETHANOL

TOXICOLOGY

Alcoholic Liver Injury in the Rat Is Associated with Reduced Expression of Peroxisome Proliferator-{alpha} (PPAR{alpha})-Regulated Genes and Is Ameliorated by PPAR{alpha} Activation

Amin A. Nanji, Andrew J. Dannenberg, Kalle Jokelainen, and Nathan M. Bass

Department of Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania (A.A.N.); Department of Medicine, Weill Medical College of Cornell University and Nutrition Center at Strang Cancer Prevention Center, New York, New York (A.J.D.); Research Unit of Alcohol Diseases, Helsinki University Central Hospital, Helsinki, Finland (K.J.); and Department of Medicine, University of California, San Francisco, California (N.M.B.)

Alcoholic liver disease is associated with a state of hepatic fatty acid overload. We examined the effect of ethanol and different types of dietary fat on the expression of mRNA for liver fatty acid binding protein (L-FABP), peroxisome proliferator-activated receptor-{alpha} (PPAR{alpha}), and peroxisomal fatty acyl CoA oxidase (FACO). Four groups of rats (n = 5) were fed intragastrically, a liquid diet with or without ethanol (10–16 g/kg/day) for 4 weeks. Pair-fed controls received isocaloric amounts of dextrose. The source of fat was either corn oil or fish oil. Ethanolfed rats developed fatty liver, necrosis, and inflammation; the changes were more severe in the fish oil-ethanol (FE) rats. PPAR{alpha} mRNA levels were not different between groups, although there was a trend toward increased levels in ethanol-fed rats. We calculated L-FABP/PPAR{alpha} and FACO/PPAR{alpha} ratios as a measure of FACO and L-FABP up-regulation relative to PPAR{alpha} expression. Both FACO/PPAR{alpha} and L-FABP/PPAR{alpha} ratios were significantly decreased in FE rats. However, only L-FABP/PPAR{alpha} was decreased in corn oil plus ethanol rats. Also, the level of L-FABP/mRNA correlated inversely with the degree of fatty liver in ethanol-fed rats. Since expression of PPAR{alpha} response genes was impaired in ethanol-fed rats, we determined whether activation of PPAR{alpha} would normalize the PPAR{alpha} response and prevent the pathological changes in ethanol-fed rats. Treatment with clofibrate, a PPAR{alpha}-activating ligand, led to a marked decrease in fatty liver and complete abrogation of necroinflammatory changes in FE rats. Also, nuclear factor {kappa}B activation and up-regulation of tumor necrosis factor-{alpha} and cyclooxygenase-2 was also abolished in clofibrate-treated rats. We conclude that adaptive gene regulation of FACO and L-FABP by PPAR{alpha} is impaired in ethanol-fed rats and that treatment with clofibrate, a PPAR{alpha} ligand, prevents alcohol-induced pathological liver injury, possibly by reversing the above changes.


Received December 19, 2003; accepted March 10, 2004.

Address correspondence to: Dr. Amin A. Nanji, Department of Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, 3400 Spruce Street, Founders 7.103, Philadelphia, PA 19104-4283. E-mail: amin.nanji{at}uphs.upenn.edu




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Sozio and D. W. Crabb
Alcohol and lipid metabolism
Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E10 - E16.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.